22.02.2013 Views

Asbestos Fibers and Other Elongate Mineral Particles: State of the ...

Asbestos Fibers and Other Elongate Mineral Particles: State of the ...

Asbestos Fibers and Other Elongate Mineral Particles: State of the ...

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

In <strong>the</strong> second phase <strong>of</strong> cellular response to EMPs,<br />

<strong>the</strong> central dogma <strong>of</strong> intracellular response is<br />

being intensively researched. The initial extracellular<br />

primary damage induces intracellular<br />

signaling (e.g., by MAPK), which causes a cascade<br />

<strong>of</strong> kinase activities that stimulate selective<br />

nuclear transcription <strong>of</strong> mRNAs, leading to<br />

production <strong>of</strong> TNF-α or o<strong>the</strong>r cytokines for extracellular<br />

signaling <strong>of</strong> target cells. Those o<strong>the</strong>r<br />

cytokines may induce cell proliferation toward<br />

cancer or collagen syn<strong>the</strong>sis toward fibrosis.<br />

Fur<strong>the</strong>r definition <strong>of</strong> signaling mechanisms <strong>and</strong><br />

analyses <strong>of</strong> <strong>the</strong>ir induction by different primary<br />

EMP-cellular interactions may better define <strong>the</strong><br />

ultimate role <strong>of</strong> EMP properties in <strong>the</strong> overall<br />

process. That research, again, may be facilitated<br />

by using different specific types <strong>of</strong> EMPs, each<br />

with relatively homogeneous morphology <strong>and</strong><br />

surface properties.<br />

Although full investigation <strong>of</strong> biopersistence<br />

<strong>of</strong> EMPs may require long-term animal model<br />

studies, in vitro systems coupled with advanced<br />

surface analytical tools (e.g., field emission<br />

SEM–energy dispersive X-ray spectroscopy or<br />

scanning Auger spectroscopy) may help guide<br />

in vivo studies. This could be done by detailing<br />

specific surface properties <strong>of</strong> EMPs <strong>and</strong> <strong>the</strong>ir<br />

modifications under cell-free or in vitro conditions<br />

representing <strong>the</strong> local pH <strong>and</strong> reactive<br />

species at <strong>the</strong> EMP surface under conditions<br />

<strong>of</strong> extracellular, intra-phagolysosomal, or frustrated<br />

annular phagocytic environments.<br />

3.4.2 Conduct Animal Studies to<br />

Ascertain <strong>the</strong> Physical <strong>and</strong><br />

Chemical Properties that<br />

Influence <strong>the</strong> Toxicity <strong>of</strong><br />

<strong>Asbestos</strong> <strong>Fibers</strong> <strong>and</strong> <strong>O<strong>the</strong>r</strong> EMPs<br />

A multispecies testing approach has been recommended<br />

for short-term assays [ILSI 2005]<br />

78<br />

<strong>and</strong> chronic inhalation studies [EPA 2000]<br />

that would provide solid scientific evidence<br />

on which to base human risk assessments for a<br />

variety <strong>of</strong> EMPs. To date, <strong>the</strong> most substantial<br />

base <strong>of</strong> human health data for estimating lung<br />

cancer risk is for workers exposed to fibers<br />

from different varieties <strong>of</strong> asbestos minerals.<br />

There are similarities between animal species<br />

<strong>and</strong> humans in deposition, clearance, <strong>and</strong> retention<br />

<strong>of</strong> inhaled particles in <strong>the</strong> lungs. For<br />

example, peak alveolar deposition fraction is<br />

greatest for particles at an AED <strong>of</strong> about 2 µm in<br />

humans <strong>and</strong> about 1 µm for rodents. However,<br />

some interspecies differences have been identified.<br />

Variations in ventilation, airway anatomy,<br />

<strong>and</strong> airway cell morphology <strong>and</strong> distribution account<br />

for quantitative differences in deposition<br />

pattern <strong>and</strong> rate <strong>of</strong> clearance among species. In<br />

addition, <strong>the</strong> efficacy <strong>of</strong> pulmonary macrophage<br />

function differs among species. All <strong>the</strong>se differences<br />

could affect particle clearance <strong>and</strong> retention.<br />

It has been suggested that <strong>the</strong> following<br />

species differences should be considered in <strong>the</strong><br />

design <strong>of</strong> experimental animal inhalation studies<br />

<strong>of</strong> elongate particles [Dai <strong>and</strong> Yu 1988; Warheit<br />

et al. 1988; Warheit 1989].<br />

• Due to differences in airway structure,<br />

airway size, <strong>and</strong> ventilation parameters, a<br />

greater fraction with large AED particles<br />

are deposited in humans than in rodents.<br />

• Alveolar deposition fraction in humans<br />

varies with workload. An increase in <strong>the</strong><br />

workload reduces <strong>the</strong> deposition fraction<br />

in <strong>the</strong> alveolar region because more <strong>of</strong><br />

<strong>the</strong> inhaled particulate is deposited in <strong>the</strong><br />

extra-thoracic <strong>and</strong> bronchial regions.<br />

• Mouth breathing by humans results in a<br />

greater upper bronchial deposition <strong>and</strong><br />

enhanced particle penetration to <strong>the</strong> peripheral<br />

lung.<br />

NIOSH CIB 62 • <strong>Asbestos</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!